Table 1 Overview of GWAS used for exposures and outcomes.

From: Genetic association between immune-mediated inflammatory diseases and peripheral artery disease: a Mendelian randomization study

Variables

Data source

Phenotypic code

Sample size

Case

Control

No. SNPs

RA

Ha E et al.50

ebi-a-GCST90013534

58,284

14,361

43,923

13,108,512

UC

De Lange KM et al.20

ebi-a-GCST004133

45,975

12,366

33,609

9,474,559

CD

De Lange KM et al.20

ebi-a-GCST004132

40,266

12,194

28,072

9,457,998

SLE

Bentham J et al.51

ebi-a-GCST003156

14,267

5,201

9,066

7,071,163

AS

UK Biobank

ukb-b-88

337,159

968

336,191

10,894,596

PSO

UK Biobank

ukb-b-10537

462,933

5,314

457,619

9,851,867

MS

Andlauer et al.21

ebi-a-GCST003566

15,283

4,888

15,283

7,910,365

HT

Sakaue et al.22

ebi-a-GCST90018855

395,640

15,654

379,986

24,146,037

PAD

FinnGen

finn-b-I9_PAD

213,639

7,098

206,541

16,380,453

  1. RA rheumatoid arthritis, UC ulcerative colitis, CD Crohn’s disease, SLE systemic lupus erythematosus, AS ankylosing spondylitis, PSO psoriasis, MS multiple sclerosis, HT hashimoto thyroiditis, PAD peripheral artery disease.
Back to article page